RFLP identified by the anonymous DNA segment OL VII E10 at 18q21.3 (HGM no. D18S8).

Por Marlhens, F, Delattre, O, Bernard, A, Olschwang, S, Dutrillaux, B, Thomas, G
Publicado em 1987

RFLP identified by the anonymous DNA segment FZ VI A2 at 22q11.2 [HGM no. D22S20]

Por Zhang, F R, Monpezat, J P, Delattre, O, Aurias, A, Thomas, G
Publicado em 1988

Simultaneous localization of cosmids and chromosome R-banding by fluorescence microscopy: application to regional mapping of human chromosome 11.

Por Cherif, D, Julier, C, Delattre, O, Derré, J, Lathrop, G M, Berger, R
Publicado em 1990

RFLP identified by the anonymous DNA segment OL VII A8 at 18q11 (HGM8 no. D18S7).

Por Delattre, O, Bernard, A, Marlhens, F, Monpezat, J P, Dutrillaux, B, Thomas, G
Publicado em 1987

RFLP identified by the anonymous DNA segment OLVIIF5 at 21q22.1-22.3 [HGM9 no.D21S143]

Por Delattre, O, Zhang, F R, Gross, M S, N'guyen, V C, Thomas, G
Publicado em 1989

INI1 mutations in meningiomas at a potential hotspot in exon 9

Por Schmitz, U, Mueller, W, Weber, M, Sévenet, N, Delattre, O, Deimling, A von
Publicado em 2001

RFLP identified by the anonymous DNA segment OLVIID1 on chromosome 6 [HGM9 no.D6S47]

Por Delattre, O, Gross, M S, de Taud, M F, N'guyen, V C, Thomas, G
Publicado em 1989

Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction.

Por Peter, M., Magdelenat, H., Michon, J., Melot, T., Oberlin, O., Zucker, J. M., Thomas, G., Delattre, O.
Publicado em 1995

DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.

Por Bailly, R A, Bosselut, R, Zucman, J, Cormier, F, Delattre, O, Roussel, M, Thomas, G, Ghysdael, J
Publicado em 1994

Parental origin of chromosome 22 alleles lost in meningioma.

Por Sanson, M, Delattre, O, Couturier, J, Philippon, J, Cophignon, J, Derome, P, Rouleau, G A, Thomas, G
Publicado em 1990

Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.

Por May, W A, Gishizky, M L, Lessnick, S L, Lunsford, L B, Lewis, B C, Delattre, O, Zucman, J, Thomas, G, Denny, C T
Publicado em 1993

Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data.

Por Zoubek, A., Pfleiderer, C., Salzer-Kuntschik, M., Amann, G., Windhager, R., Fink, F. M., Koscielniak, E., Delattre, O., Strehl, S., Ambros, P. F.
Publicado em 1994

Isolation and characterization of an alphoid DNA sequence recently amplified on human chromosome 3.

Por Delattre, O, Bernard, A, Malfoy, B, Marlhens, F, Viegas-Pequignot, E, Brossard, C, Haguenauer, O, Creau-Goldberg, N, Van Cong, N, Dutrillaux, B
Publicado em 1987

Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome

Por BOUGEARD, G., LIMACHER, J., MARTIN, C., CHARBONNIER, F., KILLIAN, A., DELATTRE, O., LONGY, M., JONVEAUX, P., FRICKER, J., STOPPA-LYONNET, D., FLAMAN, J., FREBOURG, T.
Publicado em 2001

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas

Por Missiaglia, E, Shepherd, C J, Patel, S, Thway, K, Pierron, G, Pritchard-Jones, K, Renard, M, Sciot, R, Rao, P, Oberlin, O, Delattre, O, Shipley, J
Publicado em 2010

Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells

Por Franzetti, G-A, Laud-Duval, K, van der Ent, W, Brisac, A, Irondelle, M, Aubert, S, Dirksen, U, Bouvier, C, de Pinieux, G, Snaar-Jagalska, E, Chavrier, P, Delattre, O
Publicado no Oncogene (2017)

Incidence and prognostic value of tumour cells detected by RT–PCR in peripheral blood stem cell collections from patients with Ewing tumour

Por Vermeulen, J, Ballet, S, Oberlin, O, Peter, M, Pierron, G, Longavenne, E, Laurence, V, Kanold, J, Chastagner, P, Lejars, O, Blay, J-Y, Marec-Berard, P, Michon, J, Delattre, O, Schleiermacher, G
Publicado em 2006

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

Por Schleiermacher, G, Michon, J, Huon, I, d'Enghien, C Dubois, Klijanienko, J, Brisse, H, Ribeiro, A, Mosseri, V, Rubie, H, Munzer, C, Thomas, C, Valteau-Couanet, D, Auvrignon, A, Plantaz, D, Delattre, O, Couturier, J
Publicado em 2007

Physical mapping by FISH of the DiGeorge critical region (DGCR): Involvement of the region in familial cases

Por Desmaze, C., Prieur, M., Amblard, F., Aïkem, M., LeDeist, F., Demczuk, S., Zucman, J., Plougastel, B., Delattre, O., Croquette, M.-F., Brevière, G.-M., Huon, C., Le Merrer, M., Mathieu, M., Sidi, D., Stephan, J.-L., Aurias, A.
Publicado em 1993

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative stud...

Por Schleiermacher, G, Michon, J, Ribeiro, A, Pierron, G, Mosseri, V, Rubie, H, Munzer, C, Bénard, J, Auger, N, Combaret, V, Janoueix-Lerosey, I, Pearson, A, Tweddle, D A, Bown, N, Gerrard, M, Wheeler, K, Noguera, R, Villamon, E, Cañete, A, Castel, V, Marques, B, de Lacerda, A, Tonini, G P, Mazzocco, K, Defferrari, R, de Bernardi, B, di Cataldo, A, van Roy, N, Brichard, B, Ladenstein, R, Ambros, I, Ambros, P, Beiske, K, Delattre, O, Couturier, J
Publicado em 2011